1h Free Analyst Time
The global retinal drugs market is forecasted to grow by USD 10.01 billion during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of biosimilars and cost effective alternatives, integration of digital health and teleophthalmology platforms, strategic emphasis on patient centric care and journey optimization.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global retinal drugs market is segmented as below:
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Indication
- Macular degeneration
- Diabetic eye disease
- Others
By Drug Class
- VEGF-A antagonist
- TNF-A inhibitor
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global retinal drugs market covers the following areas:
- Global retinal drugs market sizing
- Global retinal drugs market forecast
- Global retinal drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Retinal Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Retinal Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on global retinal drugs market
6.2 Impact of geopolitical conflicts on global retinal drugs market
6.2 Impact of geopolitical conflicts on global retinal drugs market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Indication
9.1 Market segments
- Chart on Indication - Market share 2025-2030 (%)
- Data Table on Indication - Market share 2025-2030 (%)
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- Chart on Macular degeneration - Market size and forecast 2025-2030 ($ million)
- Data Table on Macular degeneration - Market size and forecast 2025-2030 ($ million)
- Chart on Macular degeneration - Year-over-year growth 2025-2030 (%)
- Data Table on Macular degeneration - Year-over-year growth 2025-2030 (%)
- Chart on Diabetic eye disease - Market size and forecast 2025-2030 ($ million)
- Data Table on Diabetic eye disease - Market size and forecast 2025-2030 ($ million)
- Chart on Diabetic eye disease - Year-over-year growth 2025-2030 (%)
- Data Table on Diabetic eye disease - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)
10 Market Segmentation by Drug Class
10.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on VEGF-A antagonist - Market size and forecast 2025-2030 ($ million)
- Data Table on VEGF-A antagonist - Market size and forecast 2025-2030 ($ million)
- Chart on VEGF-A antagonist - Year-over-year growth 2025-2030 (%)
- Data Table on VEGF-A antagonist - Year-over-year growth 2025-2030 (%)
- Chart on TNF-A inhibitor - Market size and forecast 2025-2030 ($ million)
- Data Table on TNF-A inhibitor - Market size and forecast 2025-2030 ($ million)
- Chart on TNF-A inhibitor - Year-over-year growth 2025-2030 (%)
- Data Table on TNF-A inhibitor - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Singapore - Market size and forecast 2025-2030 ($ million)
- Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
- Chart on Singapore - Year-over-year growth 2025-2030 (%)
- Data Table on Singapore - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Egypt - Market size and forecast 2025-2030 ($ million)
- Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
- Chart on Egypt - Year-over-year growth 2025-2030 (%)
- Data Table on Egypt - Year-over-year growth 2025-2030 (%)
- Chart on Chile - Market size and forecast 2025-2030 ($ million)
- Data Table on Chile - Market size and forecast 2025-2030 ($ million)
- Chart on Chile - Year-over-year growth 2025-2030 (%)
- Data Table on Chile - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Growing adoption of biosimilars and cost effective alternatives
- Integration of digital health and teleophthalmology platforms
- Strategic emphasis on patient centric care and journey optimization
- Complex reimbursement and financial pressures
- Supply chain complexity and logistics vulnerability
- Regulatory burdens and clinical trial design constraints
- Impact of drivers and challenges in 2025 and 2030
- Standardization of performance based visual assessments
- Decentralization of clinical trial operations
- AI driven optimization of trial feasibility and recruitment
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings
- SWOT
- ANI Pharmaceuticals Inc. - Overview
- ANI Pharmaceuticals Inc. - Product / Service
- ANI Pharmaceuticals Inc. - Key offerings
- SWOT
- Apellis Pharmaceuticals Inc. - Overview
- Apellis Pharmaceuticals Inc. - Product / Service
- Apellis Pharmaceuticals Inc. - Key offerings
- SWOT
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key news
- Astellas Pharma Inc. - Key offerings
- SWOT
- Bausch Lomb Corp. - Overview
- Bausch Lomb Corp. - Business segments
- Bausch Lomb Corp. - Key offerings
- Bausch Lomb Corp. - Segment focus
- SWOT
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings
- SWOT
- Celltrion Co. Ltd. - Overview
- Celltrion Co. Ltd. - Product / Service
- Celltrion Co. Ltd. - Key offerings
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key news
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
- Samsung Electronics Co. Ltd. - Overview
- Samsung Electronics Co. Ltd. - Business segments
- Samsung Electronics Co. Ltd. - Key news
- Samsung Electronics Co. Ltd. - Key offerings
- Samsung Electronics Co. Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Retinal Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Indication Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Indication - Market share 2025-2030 (%)
Exhibit 57: Data Table on Indication - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Indication
Exhibit 59: Data Table on Comparison by Indication
Exhibit 60: Chart on Macular degeneration - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Macular degeneration - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Macular degeneration - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Macular degeneration - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Diabetic eye disease - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Diabetic eye disease - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Diabetic eye disease - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Diabetic eye disease - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Indication ($ million)
Exhibit 73: Data Table on Market opportunity by Indication ($ million)
Exhibit 74: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 75: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Drug Class
Exhibit 77: Data Table on Comparison by Drug Class
Exhibit 78: Chart on VEGF-A antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on VEGF-A antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on VEGF-A antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on VEGF-A antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on TNF-A inhibitor - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on TNF-A inhibitor - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on TNF-A inhibitor - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on TNF-A inhibitor - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Drug Class ($ million)
Exhibit 87: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: AbbVie Inc. - Overview
Exhibit 219: AbbVie Inc. - Business segments
Exhibit 220: AbbVie Inc. - Key news
Exhibit 221: AbbVie Inc. - Key offerings
Exhibit 222: AbbVie Inc. - Segment focus
Exhibit 223: SWOT
Exhibit 224: Amgen Inc. - Overview
Exhibit 225: Amgen Inc. - Product / Service
Exhibit 226: Amgen Inc. - Key offerings
Exhibit 227: SWOT
Exhibit 228: ANI Pharmaceuticals Inc. - Overview
Exhibit 229: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 230: ANI Pharmaceuticals Inc. - Key offerings
Exhibit 231: SWOT
Exhibit 232: Apellis Pharmaceuticals Inc. - Overview
Exhibit 233: Apellis Pharmaceuticals Inc. - Product / Service
Exhibit 234: Apellis Pharmaceuticals Inc. - Key offerings
Exhibit 235: SWOT
Exhibit 236: Astellas Pharma Inc. - Overview
Exhibit 237: Astellas Pharma Inc. - Product / Service
Exhibit 238: Astellas Pharma Inc. - Key news
Exhibit 239: Astellas Pharma Inc. - Key offerings
Exhibit 240: SWOT
Exhibit 241: Bausch Lomb Corp. - Overview
Exhibit 242: Bausch Lomb Corp. - Business segments
Exhibit 243: Bausch Lomb Corp. - Key offerings
Exhibit 244: Bausch Lomb Corp. - Segment focus
Exhibit 245: SWOT
Exhibit 246: Bayer AG - Overview
Exhibit 247: Bayer AG - Business segments
Exhibit 248: Bayer AG - Key offerings
Exhibit 249: Bayer AG - Segment focus
Exhibit 250: SWOT
Exhibit 251: Biogen Inc. - Overview
Exhibit 252: Biogen Inc. - Product / Service
Exhibit 253: Biogen Inc. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Celltrion Co. Ltd. - Overview
Exhibit 256: Celltrion Co. Ltd. - Product / Service
Exhibit 257: Celltrion Co. Ltd. - Key offerings
Exhibit 258: SWOT
Exhibit 259: F. Hoffmann La Roche Ltd. - Overview
Exhibit 260: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 261: F. Hoffmann La Roche Ltd. - Key news
Exhibit 262: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 263: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Lupin Ltd. - Overview
Exhibit 266: Lupin Ltd. - Business segments
Exhibit 267: Lupin Ltd. - Key news
Exhibit 268: Lupin Ltd. - Key offerings
Exhibit 269: Lupin Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Novartis AG - Overview
Exhibit 272: Novartis AG - Business segments
Exhibit 273: Novartis AG - Key news
Exhibit 274: Novartis AG - Key offerings
Exhibit 275: Novartis AG - Segment focus
Exhibit 276: SWOT
Exhibit 277: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 278: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 279: Regeneron Pharmaceuticals Inc. - Key news
Exhibit 280: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 281: SWOT
Exhibit 282: Samsung Electronics Co. Ltd. - Overview
Exhibit 283: Samsung Electronics Co. Ltd. - Business segments
Exhibit 284: Samsung Electronics Co. Ltd. - Key news
Exhibit 285: Samsung Electronics Co. Ltd. - Key offerings
Exhibit 286: Samsung Electronics Co. Ltd. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Viatris Inc. - Overview
Exhibit 289: Viatris Inc. - Business segments
Exhibit 290: Viatris Inc. - Key news
Exhibit 291: Viatris Inc. - Key offerings
Exhibit 292: Viatris Inc. - Segment focus
Exhibit 293: SWOT
Exhibit 294: Inclusions checklist
Exhibit 295: Exclusions checklist
Exhibit 296: Currency conversion rates for US$
Exhibit 297: Research methodology
Exhibit 298: Information sources
Exhibit 299: Data validation
Exhibit 300: Validation techniques employed for market sizing
Exhibit 301: Data synthesis
Exhibit 302: 360 degree market analysis
Exhibit 303: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Retinal Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Indication Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Indication - Market share 2025-2030 (%)
Exhibit 57: Data Table on Indication - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Indication
Exhibit 59: Data Table on Comparison by Indication
Exhibit 60: Chart on Macular degeneration - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Macular degeneration - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Macular degeneration - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Macular degeneration - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Diabetic eye disease - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Diabetic eye disease - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Diabetic eye disease - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Diabetic eye disease - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Indication ($ million)
Exhibit 73: Data Table on Market opportunity by Indication ($ million)
Exhibit 74: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 75: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Drug Class
Exhibit 77: Data Table on Comparison by Drug Class
Exhibit 78: Chart on VEGF-A antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on VEGF-A antagonist - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on VEGF-A antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on VEGF-A antagonist - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on TNF-A inhibitor - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on TNF-A inhibitor - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on TNF-A inhibitor - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on TNF-A inhibitor - Year-over-year growth 2025-2030 (%)
Exhibit 86: Market opportunity by Drug Class ($ million)
Exhibit 87: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 89: Chart on Market share by geography 2025-2030 (%)
Exhibit 90: Data Table on Market share by geography 2025-2030 (%)
Exhibit 91: Chart on Geographic comparison
Exhibit 92: Data Table on Geographic comparison
Exhibit 93: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 94: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 96: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 97: Chart on Regional Comparison - North America
Exhibit 98: Data Table on Regional Comparison - North America
Exhibit 99: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 101: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Regional Comparison - Europe
Exhibit 116: Data Table on Regional Comparison - Europe
Exhibit 117: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 118: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 119: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 122: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 123: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Regional Comparison - Asia
Exhibit 146: Data Table on Regional Comparison - Asia
Exhibit 147: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 148: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 149: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 152: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 153: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 176: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 177: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 178: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 179: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 182: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 183: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Chile - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Chile - Year-over-year growth 2025-2030 (%)
Exhibit 209: Market opportunity by geography ($ million)
Exhibit 210: Data Tables on Market opportunity by geography ($ million)
Exhibit 211: Impact of drivers and challenges in 2025 and 2030
Exhibit 212: Overview on criticality of inputs and factors of differentiation
Exhibit 213: Overview on factors of disruption
Exhibit 214: Impact of key risks on business
Exhibit 215: Companies covered
Exhibit 216: Company ranking index
Exhibit 217: Matrix on companies position and classification
Exhibit 218: AbbVie Inc. - Overview
Exhibit 219: AbbVie Inc. - Business segments
Exhibit 220: AbbVie Inc. - Key news
Exhibit 221: AbbVie Inc. - Key offerings
Exhibit 222: AbbVie Inc. - Segment focus
Exhibit 223: SWOT
Exhibit 224: Amgen Inc. - Overview
Exhibit 225: Amgen Inc. - Product / Service
Exhibit 226: Amgen Inc. - Key offerings
Exhibit 227: SWOT
Exhibit 228: ANI Pharmaceuticals Inc. - Overview
Exhibit 229: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 230: ANI Pharmaceuticals Inc. - Key offerings
Exhibit 231: SWOT
Exhibit 232: Apellis Pharmaceuticals Inc. - Overview
Exhibit 233: Apellis Pharmaceuticals Inc. - Product / Service
Exhibit 234: Apellis Pharmaceuticals Inc. - Key offerings
Exhibit 235: SWOT
Exhibit 236: Astellas Pharma Inc. - Overview
Exhibit 237: Astellas Pharma Inc. - Product / Service
Exhibit 238: Astellas Pharma Inc. - Key news
Exhibit 239: Astellas Pharma Inc. - Key offerings
Exhibit 240: SWOT
Exhibit 241: Bausch Lomb Corp. - Overview
Exhibit 242: Bausch Lomb Corp. - Business segments
Exhibit 243: Bausch Lomb Corp. - Key offerings
Exhibit 244: Bausch Lomb Corp. - Segment focus
Exhibit 245: SWOT
Exhibit 246: Bayer AG - Overview
Exhibit 247: Bayer AG - Business segments
Exhibit 248: Bayer AG - Key offerings
Exhibit 249: Bayer AG - Segment focus
Exhibit 250: SWOT
Exhibit 251: Biogen Inc. - Overview
Exhibit 252: Biogen Inc. - Product / Service
Exhibit 253: Biogen Inc. - Key offerings
Exhibit 254: SWOT
Exhibit 255: Celltrion Co. Ltd. - Overview
Exhibit 256: Celltrion Co. Ltd. - Product / Service
Exhibit 257: Celltrion Co. Ltd. - Key offerings
Exhibit 258: SWOT
Exhibit 259: F. Hoffmann La Roche Ltd. - Overview
Exhibit 260: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 261: F. Hoffmann La Roche Ltd. - Key news
Exhibit 262: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 263: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Lupin Ltd. - Overview
Exhibit 266: Lupin Ltd. - Business segments
Exhibit 267: Lupin Ltd. - Key news
Exhibit 268: Lupin Ltd. - Key offerings
Exhibit 269: Lupin Ltd. - Segment focus
Exhibit 270: SWOT
Exhibit 271: Novartis AG - Overview
Exhibit 272: Novartis AG - Business segments
Exhibit 273: Novartis AG - Key news
Exhibit 274: Novartis AG - Key offerings
Exhibit 275: Novartis AG - Segment focus
Exhibit 276: SWOT
Exhibit 277: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 278: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 279: Regeneron Pharmaceuticals Inc. - Key news
Exhibit 280: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 281: SWOT
Exhibit 282: Samsung Electronics Co. Ltd. - Overview
Exhibit 283: Samsung Electronics Co. Ltd. - Business segments
Exhibit 284: Samsung Electronics Co. Ltd. - Key news
Exhibit 285: Samsung Electronics Co. Ltd. - Key offerings
Exhibit 286: Samsung Electronics Co. Ltd. - Segment focus
Exhibit 287: SWOT
Exhibit 288: Viatris Inc. - Overview
Exhibit 289: Viatris Inc. - Business segments
Exhibit 290: Viatris Inc. - Key news
Exhibit 291: Viatris Inc. - Key offerings
Exhibit 292: Viatris Inc. - Segment focus
Exhibit 293: SWOT
Exhibit 294: Inclusions checklist
Exhibit 295: Exclusions checklist
Exhibit 296: Currency conversion rates for US$
Exhibit 297: Research methodology
Exhibit 298: Information sources
Exhibit 299: Data validation
Exhibit 300: Validation techniques employed for market sizing
Exhibit 301: Data synthesis
Exhibit 302: 360 degree market analysis
Exhibit 303: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global retinal drugs market: AbbVie Inc., Amgen Inc., ANI Pharmaceuticals Inc., Apellis Pharmaceuticals Inc., Astellas Pharma Inc., Bausch Lomb Corp., Bayer AG, Biogen Inc., Celltrion Co. Ltd., Coherus Oncology Inc, F. Hoffmann La Roche Ltd., Lupin Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Samsung Electronics Co. Ltd., Sandoz Group AG, Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Ltd., Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is standardization of performance based visual assessments."
According to the report, one of the major drivers for this market is the growing adoption of biosimilars and cost effective alternatives.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- ANI Pharmaceuticals Inc.
- Apellis Pharmaceuticals Inc.
- Astellas Pharma Inc.
- Bausch Lomb Corp.
- Bayer AG
- Biogen Inc.
- Celltrion Co. Ltd.
- Coherus Oncology Inc
- F. Hoffmann La Roche Ltd.
- Lupin Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- Samsung Electronics Co. Ltd.
- Sandoz Group AG
- Santen Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Ltd.
- Viatris Inc.
